Nemluvio® (nemolizumab-ilto)
for Atopic Dermatitis – Eczema
Nemluvio (nemolizumab) is an injectable treatment for eczema (atopic dermatitis) and prurigo nodularis that helps reduce itching, inflammation, and skin lesions while improving sleep. Nemluvio works by blocking IL-31, a protein involved in itch and inflammation, providing rapid symptom relief. As an interleukin-31 receptor antagonist, it helps manage prurigo nodularis by inhibiting IL-31 signaling, which contributes to itch, inflammation, and nodule formation.
